Acute phase markers in obese children and adolescents with metabolic disorders by Esquivel, Idalia Cura et al.
Arch Argent Pediatr 2018;116(4):275-282  /  275 Brief reports
ABSTRACT
Introduction. Obesity is a worldwide public health problem 
and the most common non-communicable chronic disease. It 
is associated with an increase in inflammatory acute phase 
proteins and proinflammatory cytokines.
Objective. To assess the levels of acute phase proteins in obese 
children and adolescents with hepatic steatosis and metabolic 
syndrome.
Methodology. Forty-five children with a body mass index ≥ 95th 
percentile aged 5.0-15.5 years were included. The following 
acute phase reactants were determined: C-reactive protein, 
haptoglobin, alpha-2-macroglobulin, and apolipoprotein A-1; 
besides, an ultrasound was done to assess hepatic steatosis.
Results. C-reactive protein levels increased in all patients. 
Patients with metabolic syndrome also had high levels of 
apolipoprotein A-1 and haptoglobin. Patients with hepatic 
steatosis had a significant increase in alpha-2-macroglobulin 
in addition to high C-reactive protein.
Key words: obesity, C-reactive protein, haptoglobins, alpha-2-
macroglobulins, apolipoprotein A-1.
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INTRODUCTION
Obesity is defined as an excessive body fat 
accumulation caused by a high-energy intake plus 
low energy expenditure. It is the most frequent 
non-communicable chronic disease among 
children and adults.1,2 In Mexico, the prevalence 
of overweight and obesity among schoolchildren 
is 33.2%, according to the latest National Survey on 
Nutrition and Health (ENSANUT 2016).3 Obesity 
is regulated by a series of adipokines, including 
leptin, adiponectin, haptoglobin, and serum 
amyloid. These mediators produced in adipose 
tissue induce a low-grade systemic inflammation 
and this process is a mechanism relating obesity to 
a range of associated pathologies.4 Multiple studies 
have demonstrated the association between body 
mass index (BMI) and visceral obesity and their 
complications, such as metabolic syndrome (MS), 
with high levels of non-specific inflammation 
mediators, including C-reactive protein (CRP), 
inflammatory acute phase proteins and other 
proinflammatory cytokines.4,5
The objective of this study was to assess acute 
phase proteins in obese children and adolescents 
with hepatic steatosis and MS.
POPULATION AND METHODS
Observational, longitudinal, analytical 
and prospective study conducted between 
January 2009 and December 2013. Patients 
aged 5-15.5 years, seen at the Department of 
Pediatrics of Hospital Universitario “Dr. José 
Eleuterio González” of Universidad Autónoma 
de Nuevo León (UANL), who had a BMI ≥ 95th 
percentile according to the Centers for Disease 
Control and Prevention (CDC) charts for age 
and sex were included. BMI was estimated based 
on the weight (kg)/height (m2) formula. The 
clinical and anthropometric assessment included 
weight, height, and waist circumference (WC) 
measurements; an abdominal ultrasound was 
also done to determine the presence of hepatic 
steatosis. The grade of hepatic steatosis was 
classified from 0 (without steatosis) to 3 (severe 
steatosis). The presence of MS was assessed 
based on the criteria of the International Diabetes 
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Federation (IDF), which establishes the presence 
of central obesity plus two or more clinical 
results: triglycerides ≥ 150 mg/dL, high-density 
lipoproteins (HDL) < 40 mg/dL for men and 
< 50 mg/dL for women, hypertension (blood 
pressure [BP] > 97th percentile), oral glucose 
tolerance test > 100 or type 2 diabetes mellitus 
(DM), waist circumference ≥ 90th percentile.6 
Patients previously diagnosed with acute or 
chronic liver disease, endocrinological, genetic 
or kidney disorders, or those who refused to 
participate in the study were excluded.
For the determination of acute phase proteins 
and liver function tests, 8 mL of blood (5 mL 
for serum and 3 mL for blood with EDTA) 
were collected. CRP, haptoglobin, alpha-2-
macroglobulin (α2M), and apolipoprotein A-1 
(APO A-1) were measured in serum.
The descriptive analysis of continuous 
outcome measures was expressed as mean ± 
standard deviation (SD). Categorical outcome 
measures were indicated as frequency and 
propor t ions .  The  re la t ionsh ip  be tween 
biochemical tests and acute inflammatory markers 
was analyzed using Spearman’s correlation for 
non-parametric data and Pearson’s correlation 
for parametric data. The SPSS statistical software, 
version 16.0, was used to this end. A value of p < 
0.05 was considered statistically significant.
Ethical aspects
This study was approved by the Ethics 
Committee of our institution (PE08-008). All 
patients gave their assent, and their parents 
signed an informed consent form.
RESULTS
A total of 45 patients were included; 19 (46%) 
were girls and 26 (57.8%), boys. The mean age 
of the group was 11 ± 2.2 years (5-15 years). The 
BMI was 27.07 ± 5.9 kg/m2 of body surface area 
(BSA) (22.4-37.8 kg/m2 of BSA). All patients 
were diagnosed with obesity based on their BMI 
percentile. The WC was 90 ± 17 cm with a waist/
hip ratio of 0.85 ± 0.18 cm.
Acute phase reactants
O n l y  C R P  ( 4 . 6 5  ±  5 . 5  m g / d L  v e r s u s 
0.25 ± 0.33 mg/dL, p < 0.001) showed significantly 
high levels in all patients. When assessing levels 
by sex, girls had higher levels than boys (5.72 ± 7.5 
versus 3.34 ± 3.77 mg/dL, p= 0.02), contrary to 
what was observed with α2M, which was higher 
in boys (3.05 ± 0.60 versus 2.74 ± 0.43 mg/dL, 
p < 0.05). When correlating anthropometric and 
biochemical parameters and acute phase proteins, 
a positive correlation was observed between CRP 
and BMI (r= 0.34, p < 0.01), CRP and WC (r= 0.76, 
p < 0.001), CRP and gamma-glutamyl transferase 
Table 1. Correlation among anthropometric and biochemical outcome measures
N= 45
Outcome measure BMI Triglycerides TC ALT AST GGT Glucose CRP
Triglycerides 0.08/0.57       
TC -0.13/0.37 0.58/0.70      
ALT -0.09/0.95 -0.23/0.87 0 .98/0.52      
AST -0.22/0.14 -0.16/0.29 0.99/0.51 0.68/0.01    
AP -0.15/0.31 0.61/0.69 0.14/0.33 0.24/0.10 0.11/0.45   
GGT 0.78/0.61 0.98/0.52 0.82/0.59 0.51/0.01 0.44/0.02   
Glucose 0.28/0.05 0.45/0.77 0.29/0.04 0.11/0.23 0.21/0.15 0.21/0.15  
CRP 0.34/0.01 0.53/0.72 -0.45/0.76 0.06/0.69 0.38/0.80 0.38/0.04 0.13/0.38 
α2M 0.06/0.97 0.06/0.68 0.29/0.05 -0.02/0.87 -0.12/0.40 0.04/0.97 0.09/0.55 -0.29/0.04
APO A-1 0.22/0.13 -0.20/0.05 0.20/0.17 0.13/0.39 0.10/0.48 0.08/0.58 0.30/0.03  0.32/0.03
Haptoglobin -0.20/0.18 0.02/0.89 0.56/0.01 0.25/0.09 0.34/0.02 0.20/0.16 -0.09/0.52 0.12/0.40
BMI: body mass index; TC: total cholesterol; ALT: alanine aminotransferase; AST: aspartate aminotransferase;  
AP: alkalinephosphatase; GGT: gamma-glutamyl transferase; CRP: C-reactive protein; α2M: alpha-2-macroglobulin;  
APO A-1: apolipoprotein A-1.
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(GGT) (r= 0.38, p < 0.04), CRP and α2M (r= 0.29, 
p < 0.04), and CRP and APO A-1 (r= 0.32, p < 0.03) 
(Table 1).
Obesity and metabolic syndrome
Based on the IDF’s criteria, 24 (53%) patients, 
8 girls and 16 boys, were diagnosed with MS. 
CRP levels were higher in patients with MS 
(4.05 ± 5.1 versus 2.15 ± 4.7 mg/dL, p < 0.001). A 
progressive rise was observed as the number of 
MS components increased. The mean CRP level 
among patients with 0, 1, 2, 3, and 4 components 
of MS was 2.6, 2.52, 2.86, 6.04, and 16.5 mg/dL, 
respectively. APO A-1 levels (1.14 ± 0.33 versus 
0.50 ± 0.56 mg/dL, p < 0.001) and haptoglobin 
levels (1.46 ± 0.26 versus 1.30 ± 0.27 mg/dL, 
p < 0.001) were higher and statistically significant, 
whereas α2M was slightly higher in the MS 
group, without a significant difference (p= 0.08) 
(Figure 1).
Obesity and hepatic steatosis
Hepatic steatosis was diagnosed by ultrasound 
in 21 (46.6%) patients; 13 had mild steatosis; 
6, moderate steatosis; and 2, severe steatosis. 
CRP levels (5.2 ± 6.6 mg/dL versus 1.9 ± 3.6 mg/
dL, p < 0.001) and α2M levels (3.12 ± 0.68 versus 
2.75 ± 0.35 mg/dL, p= 0.03) were significantly 
higher among patients with hepatic steatosis, 
whereas haptoglobin levels (1.44 ± 0.27 versus 
1.38 ± 0.23 mg/dL, p= 0.82) and APO A-1 levels 
(1.15 ± 0.29 versus 1.05 ± 0.537 mg/dL, p= 0.09) 
did not show a statistically significant difference 
(Figure 2).
DISCUSSION
CRP and other acute phase reactants have 
been involved in the diagnosis of inflammation 
described in obese patients. Α2M is a liver protein 
that, in patients with nonalcoholic fatty liver, has 
been associated with the fibrogenesis process. 
APO A-1, which is also synthesized by the liver, 
is the main component of HDL, plays a role 
in cholesterol homeostasis, and decreases as 
liver fibrosis and cirrhosis progress, whereas 
haptoglobin, also synthesized by the liver, reduces 
during fibrogenesis.7,8 Our results evidence a 
positive correlation between a high BMI and acute 
phase reactants.
A liver ultrasound is a safe, well-tolerated, 
cost-effective, easily-available, and widely 
accepted imaging test to diagnose fatty liver. 
Recent studies have demonstrated that it is 
sensitive enough to detect an amount of steatosis 
as low as 10-20%. 9 Hepatic steatosis was 
diagnosed by ultrasound in 21 patients and was, 
Figure 1. Acute phase protein levels in patients with and without metabolic syndrome
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MS: metabolic syndrome; CRP: C-reactive protein; APO A-1: apolipoprotein A-1; α2M: alpha-2-macroglobulin.
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in most cases, mild, with significantly higher CRP 
and α2M levels than in patients without steatosis. 
Our findings are consistent with what has been 
observed in previous studies, thus suggesting a 
low-grade inflammation in the liver.
Some authors, such as Bogdanski et al. and 
Vallianou et al., assessed acute phase reactants 
(CRP, haptoglobin, α2M) in patients with MS 
and found that these proteins were significantly 
high in these patients. They suggested that both 
CRP and haptoglobin may serve as markers of 
MS severity.7,10 That study on CRP, showed that 
APO A-1 and haptoglobin were significantly 
high in patients with MS, also in association with 
a chronic inflammation concurrent with other 
pathologies developed with steatosis and fibrosis, 
as observed in hepatitis C.11
In our study, CRP and APO A-1 were associated 
with obesity and MS, whereas BMI and CRP were 
strongly associated with the severity of steatosis.
The weaknesses of our study were, above all, 
the number of patients and the wide age range, 
which restricted our analysis. Pubertal stage was 
not considered either, which might have shown 
differences in findings, especially if the effect of 
estrogens on transcriptional control, clearance, 
and regulation of some of the liver-produced 
proteins (cytokines) –including CRP– had been 
considered, which could have influenced the 
outcomes.
To sum up, all patients showed an increase in 
the CRP level, regardless of BMI and metabolic 
status. Patients with MS also showed high APO 
A-1 and haptoglobin levels, whereas patients with 
hepatic steatosis also had a significant increase 
of α2M. n
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ABSTRACT
Introduction. Drug poisoning among children is a frequent 
reason for visits to the emergency department; among 
adolescents, it is intentional.
Objective. To describe the characteristics of drug poisoning 
among adolescents admitted to the municipal hospital of 
Bahía Blanca.
Material and method. Descriptive study based on the review 
of medical records of patients aged 10-19 years seen for drug 
poisoning between 2012 and 2016. The following outcome 
measures were analyzed: age, sex, drug used, cause, clinical 
manifestations, and length of stay in days.
Results. Data from 72 patients were collected. Their mean age 
was 16 years, and the female:male ratio was 2.5:1. Anxiolytic 
poisoning (30%) predominated, followed by polydrug use 
(25%). Ninety-five percent of patients showed a suicidal 
intention; of these, 55% had a history of suicide attempt.
Conclusion. Drug poisoning was observed predominantly 
among girls; it is worth noting the high percentage of youth 
who had a history of suicide attempt.
Key words: adolescent, drug poisoning.
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INTRODUCTION
In recent years, drug poisoning among 
adolescents has become a serious public health 
problem, especially in the field of pediatrics. It 
is the cause of up to 10% of all admissions to 
the intensive care unit, and the mortality rate is 
highly variable depending on the different health 
care scenarios.1
The substances involved vary greatly; 
antidepressants, anxiolytics, and non-steroidal 
anti-inflammatory drugs are the most common 
drug groups seen in these cases.2 Suicide attempt 
is the main cause of drug poisoning and one of 
the most concerning problems among individuals 
in this age group.3
At present, this is not an isolated phenomenon, 
but quite an everyday thing, especially among 
adolescents who are more prone to risk behaviors, 
given the changes typical of this development 
stage and the effect of an increasingly weakening 
of their social ties.
Considering the major role of this type of 
visits at the emergency department and because 
of the need to collect data to supplement local 
information, we decided to carry out a research 
study to describe the characteristics of the 
epidemiological patterns of drug poisoning 
among adolescents aged 10-19 years admitted to 
the emergency department of Hospital Municipal 
de Agudos “Dr. Leónidas Lucero” (HMALL).
METHODOLOGY
Descriptive, retrospective study based on the 
data collected from reviewing the medical records 
of patients aged 10-19 years seen at the emergency 
department of HMALL due to drug poisoning 
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